CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 12 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $110,000 | +5.8% | 110,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $104,000 | +1.0% | 110,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $103,000 | 0.0% | 110,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $103,000 | +2.0% | 110,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $101,000 | +3.1% | 110,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $98,000 | +2.1% | 110,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $96,000 | -82.5% | 110,000 | -82.5% | 0.00% | -66.7% |
Q3 2019 | $550,000 | -2.1% | 630,000 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $562,000 | +15.6% | 630,000 | +21.2% | 0.00% | 0.0% |
Q1 2019 | $486,000 | -29.9% | 520,000 | -37.0% | 0.00% | -33.3% |
Q4 2018 | $693,000 | -10.5% | 825,000 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $774,000 | -13.1% | 825,000 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $891,000 | +16.0% | 825,000 | +25.0% | 0.01% | +20.0% |
Q1 2018 | $768,000 | -13.8% | 660,000 | 0.0% | 0.01% | -84.8% |
Q4 2017 | $891,000 | +60.0% | 660,000 | +83.3% | 0.03% | +57.1% |
Q3 2017 | $557,000 | – | 360,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
UBS OCONNOR LLC | 11,625,000 | $7,960,000,000 | 0.15% |
CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |